Latest Administration News

Lynas Rare Earths has achieved record quarterly production of key rare earth elements and reported a strong 38% increase in sales revenue, while advancing its Mt Weld expansion and signing strategic MOUs in Malaysia.

Deep Yellow Limited reported a quarterly operating cash outflow of A$6.3 million but ended June 2025 with a strong cash position of A$217 million, providing a runway of 24 quarters at current spending levels.

FMR Resources has secured a conditional joint venture for a major copper-gold project in Chile, appointed a new managing director, and raised $2.2 million, while progressing exploration in Canada’s rare earth elements sector.

Pioneer Lithium has defined a conservative uranium Exploration Target at its Warmbad Project in Namibia, revealing significant potential for resource expansion through modern exploration techniques.

Triton Minerals has officially secured exploration licenses for its Aucu Gold-Copper Project in Mozambique and received $8.5 million in funding, positioning the company to advance exploration activities.

Sayona Mining has updated its timetable for the merger with Piedmont Lithium, conditional placement, and share consolidation, aiming to simplify and speed up the process pending shareholder approval.

Lachlan Star Limited reports promising maiden drilling results at its Killaloe Gold Project in Western Australia and initiates copper-gold drilling at North Cobar, NSW, while securing permits for further Basin Creek exploration.

One Click Group Limited has outpaced its entire July 2024 revenue within the first 18 days of July 2025, defying a broader decline in tax lodgements and showcasing strong customer loyalty.

Argenica Therapeutics has dosed the final patient in its Phase 2 trial for ARG-007 in acute ischaemic stroke, with topline results expected in Q3 2025. Meanwhile, the FDA has placed a clinical hold on its US trial application, introducing uncertainty for US development.

Paladin Energy reported a $18.4 million operating cash outflow in Q2 2025 but maintains a strong liquidity position with $89 million in cash and $139 million in total available funding.

Plenti Group has reported a third consecutive record quarter with $437 million in loan originations, driven by strong automotive and NAB partnership growth. The fintech lender also secured a key government contract and continues to deliver low credit losses.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.